Iceland vs Marshall Islands: Previously treated cases tested for RR-/MDR-TB
Iceland
100.0%
in 2022
Marshall Islands
100.0%
in 2024
Iceland rank
1st
Marshall Islands rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iceland
- Marshall Islands
How they compare
Iceland currently reports 100.0% against 100.0% in Marshall Islands, a difference of 0.0%.
The two have swapped places 5 times across 8 shared years of data; in 2005 it was Iceland ahead.
Iceland ranks 1st and Marshall Islands ranks 1st of 180 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iceland | Marshall Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 83.3% | 67.0% | 16.3% | Iceland |
| 2010s | 62.5% | 25.2% | 37.2% | Iceland |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iceland or Marshall Islands?
- Iceland, at 100.0% against 100.0% in Marshall Islands as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iceland and Marshall Islands?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Marshall Islands?
- 8 years are reported by both, from 2005 to 2022.
- How do Iceland and Marshall Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Marshall Islands ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.